678dkk
0,0 %
Date:2025-05-13Time:17:20:00Latest report:Q1-2025List:First NorthTicker:VIRO
Market Cap:52 mdkkEnterprise Value:47 mdkkNet Sales:4,90 mdkkEarnings:-13,5 mdkkEmployees:0ISIN:DK0061030574

Ratios

10-year key figure history for ViroGates turnover, profit, dividend, equity, PE and PB.

Pre
Pre

Stockprice

Price movement for ViroGates with index and moving average MA50 and MA200.

Stockprice:6,78
MA50:7,47
MA200:9,09
Price/MA200:-25,4 %
RSI (14):49,1
Price/MA50:-9,3 %

Description

Virogates is a medical technology company. Business operations are conducted within the research and development of biomarkers and diagnostic instruments for the healthcare industry. The products are sold under various brands and are used in the identification, analysis, and further treatment of diseases, mainly cardiovascular diseases, cancer, and neurological diseases. The company was established in 2001 and is headquartered in Birkerød.

Medical Equipment